Cargando…

Comparison of abo antibody levels in apheresis platelets suspended in platelet additive solution and plasma

BACKGROUND: Transfusion of platelets (PLTs) with high ABO antibody titres can pose a risk of hemolysis if the unit crosses the ABO type. The PLTs stored in the platelet additive solution (PAS) remove asubstantial fraction of plasma and replace it with an isotonicbuffered solution.We aimed to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: KC, Gayathiri, Murugesan, Mohandoss, Nayanar, Sangeetha K., Malodan, Riyas, Padmanaban, Maya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211627/
https://www.ncbi.nlm.nih.gov/pubmed/32571673
http://dx.doi.org/10.1016/j.htct.2020.03.008
_version_ 1783709504678920192
author KC, Gayathiri
Murugesan, Mohandoss
Nayanar, Sangeetha K.
Malodan, Riyas
Padmanaban, Maya
author_facet KC, Gayathiri
Murugesan, Mohandoss
Nayanar, Sangeetha K.
Malodan, Riyas
Padmanaban, Maya
author_sort KC, Gayathiri
collection PubMed
description BACKGROUND: Transfusion of platelets (PLTs) with high ABO antibody titres can pose a risk of hemolysis if the unit crosses the ABO type. The PLTs stored in the platelet additive solution (PAS) remove asubstantial fraction of plasma and replace it with an isotonicbuffered solution.We aimed to assess the difference in anti-A/B antibody levels in Groups O, A and B apheresis platelets (APs) suspended in plasma and PAS. METHODOLOGY: Apheresis donors are categorized into two groups, Plasma (Group I) and PAS (Group II), each blood group (A, B and O) had 20 samples. The anti-A/B(IgM)antibody levels were recorded from the AP donor (Group II) and from the AP units for both groups. The reduction in the anti-A/B(IgM) antibody levels in the APs suspended in the PAS for each blood group was determined. RESULTS: The median anti-A titres in blood Groups B (p = 0.009) and O (p = 0.005) was significantly lower in Group II. However, the difference in anti-B levels was not significant in the blood groups A (p = 0.057) and O (p = 0.205). The median level of reduction in IgM antibody titres across donor samples and the PAS-stored platelets was two-fold. The regression showed a level of reduction in antibody titres which can be explained by baseline donor antibody titres in blood groups A and B compared to blood group O. CONCLUSION: The medianABO antibody titres were lower in APs suspended in PAS than in plasma. Addition of the PAS significantly lowered the IgM antibody titres by twofold, compared to plasma.
format Online
Article
Text
id pubmed-8211627
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Sociedade Brasileira de Hematologia e Hemoterapia
record_format MEDLINE/PubMed
spelling pubmed-82116272021-06-25 Comparison of abo antibody levels in apheresis platelets suspended in platelet additive solution and plasma KC, Gayathiri Murugesan, Mohandoss Nayanar, Sangeetha K. Malodan, Riyas Padmanaban, Maya Hematol Transfus Cell Ther Original Article BACKGROUND: Transfusion of platelets (PLTs) with high ABO antibody titres can pose a risk of hemolysis if the unit crosses the ABO type. The PLTs stored in the platelet additive solution (PAS) remove asubstantial fraction of plasma and replace it with an isotonicbuffered solution.We aimed to assess the difference in anti-A/B antibody levels in Groups O, A and B apheresis platelets (APs) suspended in plasma and PAS. METHODOLOGY: Apheresis donors are categorized into two groups, Plasma (Group I) and PAS (Group II), each blood group (A, B and O) had 20 samples. The anti-A/B(IgM)antibody levels were recorded from the AP donor (Group II) and from the AP units for both groups. The reduction in the anti-A/B(IgM) antibody levels in the APs suspended in the PAS for each blood group was determined. RESULTS: The median anti-A titres in blood Groups B (p = 0.009) and O (p = 0.005) was significantly lower in Group II. However, the difference in anti-B levels was not significant in the blood groups A (p = 0.057) and O (p = 0.205). The median level of reduction in IgM antibody titres across donor samples and the PAS-stored platelets was two-fold. The regression showed a level of reduction in antibody titres which can be explained by baseline donor antibody titres in blood groups A and B compared to blood group O. CONCLUSION: The medianABO antibody titres were lower in APs suspended in PAS than in plasma. Addition of the PAS significantly lowered the IgM antibody titres by twofold, compared to plasma. Sociedade Brasileira de Hematologia e Hemoterapia 2021 2020-06-15 /pmc/articles/PMC8211627/ /pubmed/32571673 http://dx.doi.org/10.1016/j.htct.2020.03.008 Text en © 2020 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
KC, Gayathiri
Murugesan, Mohandoss
Nayanar, Sangeetha K.
Malodan, Riyas
Padmanaban, Maya
Comparison of abo antibody levels in apheresis platelets suspended in platelet additive solution and plasma
title Comparison of abo antibody levels in apheresis platelets suspended in platelet additive solution and plasma
title_full Comparison of abo antibody levels in apheresis platelets suspended in platelet additive solution and plasma
title_fullStr Comparison of abo antibody levels in apheresis platelets suspended in platelet additive solution and plasma
title_full_unstemmed Comparison of abo antibody levels in apheresis platelets suspended in platelet additive solution and plasma
title_short Comparison of abo antibody levels in apheresis platelets suspended in platelet additive solution and plasma
title_sort comparison of abo antibody levels in apheresis platelets suspended in platelet additive solution and plasma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211627/
https://www.ncbi.nlm.nih.gov/pubmed/32571673
http://dx.doi.org/10.1016/j.htct.2020.03.008
work_keys_str_mv AT kcgayathiri comparisonofaboantibodylevelsinapheresisplateletssuspendedinplateletadditivesolutionandplasma
AT murugesanmohandoss comparisonofaboantibodylevelsinapheresisplateletssuspendedinplateletadditivesolutionandplasma
AT nayanarsangeethak comparisonofaboantibodylevelsinapheresisplateletssuspendedinplateletadditivesolutionandplasma
AT malodanriyas comparisonofaboantibodylevelsinapheresisplateletssuspendedinplateletadditivesolutionandplasma
AT padmanabanmaya comparisonofaboantibodylevelsinapheresisplateletssuspendedinplateletadditivesolutionandplasma